Skip to content

Analyzing the Factors in Ulcerative Colitis Patients' Clinical Trial Experiences

An Evaluation of Clinical Study Experiences of Patients With Ulcerative Colitis

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05737836
Enrollment
500
Registered
2023-02-21
Start date
2024-03-31
Completion date
2026-03-31
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative Colitis

Keywords

Ulcerative Colitis

Brief summary

Taking part in clinical trials usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This study will admit a wide range of data on the clinical trial experience of Ulcerative Colitis patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future Ulcerative Colitis patients.

Interventions

None listed

Sponsors

Power Life Sciences Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient is at least 18 years of age * Diagnosis of Ulcerative Colitis * Ability to understand the study procedures, benefits and risks, and sign a written informed consent document.

Exclusion criteria

* Inability to perform regular electronic reporting * Women who are pregnant, intend to become pregnant, or are lactating * Inability to perform regular electronic reporting

Design outcomes

Primary

MeasureTime frame
Rate of patients who decide to join in an Ulcerative Colitis clinical trial3 months
Number of Ulcerative Colitis patients who remain in clinical trial until completion12 months

Contacts

Primary ContactMichael B Gill
bask@withpower.com415-900-4227

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026